Description

Simple

Clinical

Overview

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Geldanamycin
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Geldanamycin.
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Geldanamycin.
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Geldanamycin.
Acetaminophen
The serum concentration of Acetaminophen can be increased when it is combined with Geldanamycin.
Benzylthiouracil
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Geldanamycin.
Carbimazole
The therapeutic efficacy of Carbimazole can be decreased when used in combination with Geldanamycin.
Darbepoetin alfa
The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Geldanamycin.
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Geldanamycin.
Elcatonin
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Geldanamycin.
Erythropoietin
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin.
Follitropin
The therapeutic efficacy of Follitropin can be decreased when used in combination with Geldanamycin.
Levothyroxine
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Geldanamycin.
Liothyronine
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Geldanamycin.
Liotrix
The therapeutic efficacy of Liotrix can be decreased when used in combination with Geldanamycin.
Methimazole
The therapeutic efficacy of Methimazole can be decreased when used in combination with Geldanamycin.
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Geldanamycin.
Methylthiouracil
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Geldanamycin.
Parathyroid hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Geldanamycin.
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Geldanamycin.
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Geldanamycin.